Screener
Eligibility screening
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
3 US sites in CO, FL, NY
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.